Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians

scientific article published on 01 July 1994

Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.14.7.1084
P698PubMed publication ID8018664

P2093author name stringT A Miettinen
M J Tikkanen
R S Tilvis
K Kontula
H E Miettinen
J Louhija
P433issue7
P921main subjectgenetic variationQ349856
phenotypeQ104053
P304page(s)1084-1089
P577publication date1994-07-01
P1433published inArteriosclerosis and thrombosis : a journal of vascular biologyQ27709770
P1476titleAging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians
P478volume14

Reverse relations

cites work (P2860)
Q77894572A centenarian-only approach for assessing gene-gene interaction in human longevity
Q43887708A logistic regression model for measuring gene-longevity associations
Q57629691APOE Alleles and Extreme Human Longevity
Q36998533Age, APOE and sex: Triad of risk of Alzheimer's disease
Q41172424Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides
Q61054673Apolipoprotein E alleles in nonagenarian subjects in the Belfast Elderly Longitudinal Free-living Ageing Study (BELFAST)
Q36532904Apolipoprotein E and familial longevity
Q35538346Apolipoprotein E and mortality in African-Americans and Yoruba
Q36527527Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study
Q52024361Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease.
Q34688023Apolipoproteins and aging: emerging mechanisms
Q37274994Assessment of the contribution of APOE gene variants to metabolic phenotypes associated with familial longevity at middle age.
Q43864519Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
Q57337171Association of apolipoprotein (Apo)E genotype with plasma apo E levels
Q24796377Association of apolipoprotein E genotypes, blood pressure, blood lipids and ECG abnormalities in a general population aged 85+
Q43906238Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes
Q37414468Centenarians--a useful model for healthy aging? A 29-year follow-up of hospitalizations among 40,000 Danes born in 1905
Q34071528Common gene variants, mortality and extreme longevity in humans.
Q52029704Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians.
Q44325087Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity
Q73194210Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients
Q74308758Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes
Q34280870Exact sample size needed to detect dependence in 2 x 2 x 2 tables.
Q74190817Exercise-induced silent myocardial ischemia in master athletes
Q73574820Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis
Q40940199Genetic and aging epidemiology. The merging of two disciplines
Q37214302Genetic epidemiology in aging research
Q21143740Genetic variation in healthy oldest-old
Q54105736Genetics of longevity.
Q47987141In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians
Q81695724Laboratory parameters of Italian centenarians
Q38988292Limitations and risks of meta-analyses of longevity studies
Q35166293Methodological Considerations in Studying Centenarians: Lessons Learned From the Georgia Centenarian Studies.
Q52034585Modeling the effects of genetic factors on late-onset diseases in cohort studies.
Q36192488Molecular determinants of human longevity
Q44564480Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis
Q39654157Ninety-seven-year-old people: general presentation, and some general and medical characteristics from a Swedish population study
Q60049384Positive association of familial longevity with the moderate-high HDL-C concentration in Bama Aging Study
Q35881544Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.
Q64087216The Genetic Variability of in Different Human Populations and Its Implications for Longevity
Q30248596The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts
Q38463404The association of apolipoprotein E polymorphism with memory: a population based study
Q92252120The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)
Q44654924The normal population distribution of PRNP codon 129 polymorphism
Q37779889The role of genetic variants in human longevity
Q37413113Total and cause-specific mortality in the cardiovascular health study
Q37072970Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population
Q74622617Variations of cardiovascular disease associated genes exhibit sex-dependent influence on human longevity
Q73821380You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation

Search more.